Immunomedics Inc (IMMU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Sales | 5,653 | 9,042 | 4,962 | 32,734 | 14,710 |
| Cost of Goods | 265 | 1,528 | 393 | 427 | 419 |
| Gross Profit | 5,388 | 7,514 | 4,569 | 32,307 | 14,290 |
| Operating Expenses | 51,873 | 43,622 | 35,755 | 31,291 | 32,900 |
| Operating Income | -46,220 | -35,580 | -30,793 | 1,443 | -18,191 |
| Interest Expense | 2,091 | 0 | 0 | 0 | 0 |
| Other Income | 245 | 57 | 19,350 | 32 | 3,888 |
| Pre-tax Income | -48,066 | -35,523 | -11,442 | 1,475 | -14,303 |
| Income Tax | 58 | 8 | 44 | 210 | 110 |
| Net Income Continuous | -48,124 | -35,531 | -11,486 | 1,265 | -14,412 |
| Minority Interests | -122 | -105 | -105 | -114 | -174 |
| Net Income | $-48,002 | $-35,426 | $-11,382 | $1,378 | $-14,238 |
| EPS Basic Total Ops | -0.51 | -0.42 | -0.15 | 0.02 | -0.19 |
| EPS Basic Continuous Ops | -0.52 | -0.42 | -0.15 | 0.02 | -0.19 |
| EPS Diluted Total Ops | -0.51 | -0.42 | -0.15 | 0.02 | -0.19 |
| EPS Diluted Continuous Ops | -0.52 | -0.42 | -0.15 | 0.02 | -0.19 |
| EBITDA(a) | $-44,722 | $-37,357 | $-29,834 | $2,811 | $-16,951 |